Comparing Different Treatment Plans in Radiotherapy of Hodgkin Disease Involving Neck and Mediastinum, Using Parallel-Opposite Fields Method

Document Type : Original Article (s)

Authors

1 Professor, Department of Medical Physics and Engineering, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Medical Physics and Engineering, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Assistant Professor, Department of Radiation-Oncology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 Radiation Oncologist,, Department of Radiation-Oncology, Isfahan Milad Hospital, Isfahan, Iran

5 PhD Student, Department of Medical Physics and Engineering, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

6 PhD Student, Department of Medical Physics and Engineering, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background: Hodgkin lymphoma is one of the treatable malignant diseases. The incidence of secondary cancers, especially breast cancer, and cardiovascular diseases after radiotherapy doubles the importance of patient treatment plan. In this study, some comparisons were made between a variety of treatments by using photon energy of 6 and 18 Mv on the treated areas of neck and mediastinum.Methods: The contouring of all sensitive organs and treatment volumes were performed for 18 female patients with Hodgkin lymphoma involving neck and mediastinum, using TiGRT software. Then, comparison between different anterior-posterior (AP-PA) treatments with different weights of 6 and 18 Mv was done.Findings: Using 18-Mv photon with the same weight of the anterior and posterior than conventional 6-Mv photon caused 2-9% reduction in mean dose to breast, heart, and lungs. Although changing the normalization (isocenter) point from the center of tumor to sternal notch reduced the mean dose of the studied organs, 9-13% reduction in the mean dose of treatment volume did not meet the criterion (prescribed dose ± 105%).Conclusion: For women with Hodgkin lymphoma involving mediastinum and neck, using 18-Mv photon with the same weight of the anterior and posterior is more appropriate to meet the design criteria of treatment (coating suitable treatment volume of prescribed dose ± 105%). Changing isocenter point from the center of the tumor to sternal notch causes a more favorable result. The better uniformity of the dose distribution in treatment volume is achieved by using 18-Mv photon.

Keywords


  1. Dasher B, Wiggers N, Vann AM. Portal design in radiation therapy. Columbia, SC: R. L. Bryan Company; 1994.
  2. Davis QG, Paulino AC, Miller R, Ting JY. Mantle fields in the era of dynamic multileaf collimation: field shaping and electronic tissue compensation. Med Dosim 2006; 31(3): 179-83.
  3. Greenfield DM, Wright J, Brown JE, Hancock BW, Davies HA, O'Toole L, et al. High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screening. Br J Cancer 2006; 94(4): 469-72.
  4. Nihei K, Mitsumori M, Ishigaki T, Fujishiro S, Kokubo M, Nagata Y, et al. Determination of optimal radiation energy for different breast sizes using CT-simulator [correction of simulatior] in tangential breast irradiation. Breast Cancer 2000; 7(3): 231-6.
  5. Yang GY, McClosky SA, Khushalani NI. Principles of modern radiation techniques for esophageal and gastroesophageal junction cancers. Gastrointest Cancer Res 2009; 3(2 Suppl): S6-S10.
  6. Koh ES, Tran TH, Heydarian M, Sachs RK, Tsang RW, Brenner DJ, et al. A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk. Radiat Oncol 2007; 2: 13.
  7. Cella L, Liuzzi R, Magliulo M, Conson M, Camera L, Salvatore M, et al. Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniques. Radiat Oncol 2010; 5: 33.
  8. De Sanctis V, Bolzan C, D'Arienzo M, Bracci S, Fanelli A, Cox MC, et al. Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy? Radiat Oncol 2012; 7: 129.
  9. Tavakoli MB, Maleki M, Akhavan A, Amouheidari A, Hadisinia T, Khajooe-Fard R. Comparison of the dose distribution in the two- and four-fields treatment plannings with energy of 6 and 18 Mv in patients with Hodgkin's disease with mediastinal involvement. J Isfahan Med Sch 2016; 34(396): 991-7. [In Persian].
  10. Halperin EC, Perez CA, Brady LW. Perez and Brady's principles and practice of radiation oncology. 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2007.
  11. Schill S, Kampfer S, Hansmeier B, Nieder C, Geinitz H. Sparing of critical organs in radiotherapy of mediastinal lymphoma. In: Dossel O, Schlegel WC, editors. World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany: Vol. 25/1 Radiation Oncology. Berlin, Germany: Springer; 2009. p. 711-3.